Mechanism of hsa-miR-222-3p Targeting Integrin Subunit Beta 3 to Regulate Malignant Behavior of Colorectal Cancer HT29 Cells

Author:

Li Meng1,Ni Qianyang1,Yu Suyang1

Affiliation:

1. Department of Gastrointestinal Surgery, The Third Hospital Affiliated to Hebei Medical University, Shijiazhuang 050051, China

Abstract

Colorectal cancer (CRC) is a prevalent malignancy worldwide, and microRNAs (miRNAs) have been recognized for their significant role in CRC progression and potential as therapeutic targets. This study aimed to investigate the impact of miR-222-3p on CRC cell proliferation, migration, and invasion, along with its target genes. HT29 cells were transfected with mimic-negative control (mimic-NC) or mimic-miR-222-3p, while the control group remained untreated. Cell proliferation, migration, and invasion were assessed using CCK-8 and Transwell assays. qRT-PCR and Western blotting were employed to measure gene mRNA and protein expression, respectively. A luciferase reporter assay verified the binding between miR-222-3p and its downstream target gene ITGB3. The results revealed that enhanced miR-222-3p expression significantly increased HT29 cell proliferation, migration, and invasion. qRT-PCR and Western blotting indicated reduced expression of ITGB3 and E-cadherin, and upregulation of Vimentin and α-SMA by miR-222-3p. The luciferase reporter assay confirmed ITGB3 as a direct target of miR-222-3p. In conclusion, miR-222-3p promotes CRC progression by regulating ITGB3 expression, suggesting its potential as a crucial biomarker and therapeutic target for colorectal cancer.

Publisher

American Scientific Publishers

Subject

General Materials Science

Reference25 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;Ca-A Cancer Journal for Clinicians,2018

2. Colorectal carcinoma: A general overview and future perspectives in colorectal cancer;Marmol;International Journal of Molecular Sciences,2017

3. Clinical efficacy of bevacizumab plus XELOX chemotherapy in colorectal cancer and application value of mindfulness-based stress reduction intervention;Sun;Alternative Therapies in Health and Medicine,2022

4. MicroRNAs: Target recognition and regulatory functions;Bartel;Cell,2009

5. Construction and analysis of lncRNA-miRNAmRNA ceRNA network identify an eight-gene signature as a potential prognostic factor in kidney renal papillary cell carcinoma (KIRP);Yang;Alternative Therapies in Health and Medicine,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3